Invention Grant
- Patent Title: Treatment or prevention method of radiation damage by administration of IL-5 receptor alpha chain binding antibody
-
Application No.: US17530150Application Date: 2021-11-18
-
Publication No.: US11999788B2Publication Date: 2024-06-04
- Inventor: Kazuki Okada , Kiyotoshi Mori , Satoshi Uematsu , Naoki Takemura
- Applicant: Kyowa Kirin Co., Ltd. , The University of Tokyo
- Applicant Address: JP Tokyo
- Assignee: Kyowa Kirin Co., Ltd.,The University of Tokyo
- Current Assignee: Kyowa Kirin Co., Ltd.,The University of Tokyo
- Current Assignee Address: JP Tokyo; JP Tokyo
- Agency: Foley & Lardner LLP
- Priority: JP 17010542 2017.01.24 JP 17212459 2017.11.02
- The original application number of the division: US16480296
- Main IPC: A61K45/06
- IPC: A61K45/06 ; C07K14/715 ; C07K16/28

Abstract:
A therapeutic or prophylactic agent for radiation damage associated with radiation exposure, comprising an eosinophil-removing agent as an active ingredient and the like are provided as a technique for efficiently treating or preventing radiation damage associated with radiation exposure. According to the therapeutic or prophylactic agent comprising an eosinophil-removing agent according to the present invention, by suppressing migration and/or infiltration into target tissue and/or proliferation in the tissue of eosinophils and/or inhibiting the activity or function of the eosinophils, pathological conditions such as inflammatory responses and fibrosis of tissue can be suppressed to effectively treat or prevent radiation damage. Moreover, effective radiation therapy can be performed by suppressing radiation damage.
Public/Granted literature
Information query